TR201620103A2 - INHALATION FORMULATIONS - Google Patents

INHALATION FORMULATIONS Download PDF

Info

Publication number
TR201620103A2
TR201620103A2 TR2016/20103A TR201620103A TR201620103A2 TR 201620103 A2 TR201620103 A2 TR 201620103A2 TR 2016/20103 A TR2016/20103 A TR 2016/20103A TR 201620103 A TR201620103 A TR 201620103A TR 201620103 A2 TR201620103 A2 TR 201620103A2
Authority
TR
Turkey
Prior art keywords
pharmaceutically acceptable
acceptable derivatives
present
group
chronic
Prior art date
Application number
TR2016/20103A
Other languages
Turkish (tr)
Inventor
Erten Başaran Fatma
Original Assignee
Fatma Erten Basaran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fatma Erten Basaran filed Critical Fatma Erten Basaran
Priority to TR2016/20103A priority Critical patent/TR201620103A2/en
Publication of TR201620103A2 publication Critical patent/TR201620103A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş; astım, kronik ve akut bronşit, Kronik Obstruktif Akciğer Hastalığı (KOAH), amfizem gibi akciğer hastalıklarının profilaktik ve/veya semptomatik ve/veya terapötik tedavisinde kullanılmak üzere glukokortikoid grubunda yer alan uygun etken madde ve/veya farmasötik olarak kabul edilebilir türevlerinin, uzun etkili selektif ß2-adrenerjik agonistleri grubunda yer alan uygun etken madde ve/veya farmasötik olarak kabul edilebilir türevleri ile kombine tedavisini içeren farmasötik bileşim/ler ile ilgilidir.The present invention includes; suitable active ingredient and / or pharmaceutically acceptable derivatives of the glucocorticoid group for use in the prophylactic and / or symptomatic and / or therapeutic treatment of lung diseases such as asthma, chronic and acute bronchitis, Chronic Obstructive Pulmonary Disease (COPD), emphysema. The present invention relates to a pharmaceutical composition (s) comprising the combined treatment with the appropriate active substance and / or pharmaceutically acceptable derivatives thereof in the group of β2-adrenergic agonists.

TR2016/20103A 2016-12-29 2016-12-29 INHALATION FORMULATIONS TR201620103A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2016/20103A TR201620103A2 (en) 2016-12-29 2016-12-29 INHALATION FORMULATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/20103A TR201620103A2 (en) 2016-12-29 2016-12-29 INHALATION FORMULATIONS

Publications (1)

Publication Number Publication Date
TR201620103A2 true TR201620103A2 (en) 2018-07-23

Family

ID=64901710

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/20103A TR201620103A2 (en) 2016-12-29 2016-12-29 INHALATION FORMULATIONS

Country Status (1)

Country Link
TR (1) TR201620103A2 (en)

Similar Documents

Publication Publication Date Title
CY1120605T1 (en) DRY POWDER PREPARATION INCLUDING A PHOSPHODIESTERATION INHIBITOR
BR112015006571A2 (en) pharmaceutical composition, process for preparing a pharmaceutical composition, use of a pharmaceutical composition, and method for the prophylaxis or treatment of asthma, chronic obstructive pulmonary disease and related respiratory disorders
MX2019006938A (en) Methods and compositions for treatment of pulmonary hypertension and other lung disorders.
PH12017502087A1 (en) Tiotropium inhalation solution for nebulization
EA201590030A1 (en) DRY POWDER INHALERS, CONTAINING CARRIER, EXCELLENT FROM LACTOSE, AND THIRD COMPONENT
TR201000680A2 (en) Pharmaceutical compositions containing tiotropium, formoterol and budesonide
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
TR201000681A2 (en) Dry powder formulations inhaled.
EP2682097A3 (en) Dry Powder Inhalers Comprising A Carrier Other Than Lactose
JOP20200314A1 (en) Stable pharmaceutical compositions for pressurized metered dose inhalers
EA201201397A1 (en) INHALER CONTAINING DISTRIBUTED GLISTER PACKING
MX2022015965A (en) Combination of alcaftadine and a corticosteroid.
EA201401354A1 (en) NEW DOSED FORM AND PREPARATION CONTAINING ABEDTEROL
TR201000622A2 (en) Pharmaceutical combinations containing tiotropium.
EA201201393A1 (en) INHALER, DEVELOPED FOR DELIVERY OF MEDICINES AS DRY POWDER
UA115989C2 (en) Dry powder inhaler compositions comprising long acting muscorinic antagonists
WO2015049519A3 (en) Method and apparatus for making compositions for pulmonary administration
MX368036B (en) Inhalable particles comprising tiotropium and indacaterol.
TR201620103A2 (en) INHALATION FORMULATIONS
MY187442A (en) A pharmaceutical composition containing budesonide and formoterol
BR112017014861A2 (en) Pharmaceutical combination and composition, dry powder inhaler, use of a pharmaceutical combination, and method for treating a pulmonary disorder.
TR201712424A2 (en) DRY POWDER INHALATION COMPOSITIONS
BR112018072177A2 (en) pharmaceutical composition, container, and methods for treating and preventing nasal congestion, viral respiratory tract infections and / or throat inflammation
TR201720846A2 (en) ORAL PHARMACEUTICAL COMPONENTS
EA201201362A1 (en) PHARMACEUTICAL AEROSOL COMPOSITION PROTEASIS INHIBITORS AND ITS OBTAINING